AN2 Therapeutics, Inc. (ANTX)
NASDAQ·Healthcare·Biotechnology
$4.79
+0.10%
Mkt Cap $131.53M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$7.75
Range $2.00 – $22.00
Implied Upside
+61.8%
Consensus $7.75 vs current $4.79
NASDAQ·Healthcare·Biotechnology
$4.79
+0.10%
Mkt Cap $131.53M
No recent rating data.
Price Target (7 analysts)
$7.75
Range $2.00 – $22.00
+61.8%
Consensus $7.75 vs current $4.79